Search Results

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

This report uses 2012 Medical Expenditure Panel Survey (MEPS) data. Adults aged 18 to 64 in poor physical health who also reported behavioral health conditions (i.e., mental health or substance use disorders) had higher total health care expenditures than adults in poor health without behavioral health conditions. These higher total...

This CBHSQ short report uses data from the 2011 Treatment Episode Data Set – Discharges (TEDS-D) and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to provide a portrait of treatment discharges among those referred to treatment by the criminal justice system, hereafter referred to as criminal justice...

This report looks at SAMHSA Block Grants that serve as a safety net for individuals without health insurance or other resources who seek specialty substance use treatment and prevention services. Under the Affordable Care Act, some of the treatment options that were covered by the SAMHSA Block Grants are likely...

The Behavioral Health Equity Barometer, United States, 2014 provides a snapshot of substance use and mental health indicators by selected determinants of health: race and ethnicity, income level, geographic location, and health insurance status in the United States as measured through the National Survey on Drug Use and Health (NSDUH)...

This CBHSQ short report uses MEPS data to analyze behavioral health expenditures for adults aged 18 to 64 were eligible for both Medicaid and Medicare (dual eligible) during any given year from 2008 to 2011.

This study used data from the public use files of the 1997 to 2004 National Health Interview Survey (NHIS), which were linked to death certificate data from the 1997 to 2006 National Death Index (NDI), to assess the association between psychological distress and mortality. This study summarizes results presented in...

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.